479 related articles for article (PubMed ID: 30597610)
1. LRRK2-mediated Rab10 phosphorylation in immune cells from Parkinson's disease patients.
Atashrazm F; Hammond D; Perera G; Bolliger MF; Matar E; Halliday GM; Schüle B; Lewis SJG; Nichols RJ; Dzamko N
Mov Disord; 2019 Mar; 34(3):406-415. PubMed ID: 30597610
[TBL] [Abstract][Full Text] [Related]
2. Interrogating Parkinson's disease LRRK2 kinase pathway activity by assessing Rab10 phosphorylation in human neutrophils.
Fan Y; Howden AJM; Sarhan AR; Lis P; Ito G; Martinez TN; Brockmann K; Gasser T; Alessi DR; Sammler EM
Biochem J; 2018 Jan; 475(1):23-44. PubMed ID: 29127255
[TBL] [Abstract][Full Text] [Related]
3. The Parkinson's disease VPS35[D620N] mutation enhances LRRK2-mediated Rab protein phosphorylation in mouse and human.
Mir R; Tonelli F; Lis P; Macartney T; Polinski NK; Martinez TN; Chou MY; Howden AJM; König T; Hotzy C; Milenkovic I; Brücke T; Zimprich A; Sammler E; Alessi DR
Biochem J; 2018 Jun; 475(11):1861-1883. PubMed ID: 29743203
[TBL] [Abstract][Full Text] [Related]
4. R1441G but not G2019S mutation enhances LRRK2 mediated Rab10 phosphorylation in human peripheral blood neutrophils.
Fan Y; Nirujogi RS; Garrido A; Ruiz-Martínez J; Bergareche-Yarza A; Mondragón-Rezola E; Vinagre-Aragón A; Croitoru I; Gorostidi Pagola A; Paternain Markinez L; Alcalay R; Hickman RA; Düring J; Gomes S; Pratuseviciute N; Padmanabhan S; Valldeoriola F; Pérez Sisqués L; Malagelada C; Ximelis T; Molina Porcel L; Martí MJ; Tolosa E; Alessi DR; Sammler EM
Acta Neuropathol; 2021 Sep; 142(3):475-494. PubMed ID: 34125248
[TBL] [Abstract][Full Text] [Related]
5. Inhibitor treatment of peripheral mononuclear cells from Parkinson's disease patients further validates LRRK2 dephosphorylation as a pharmacodynamic biomarker.
Perera G; Ranola M; Rowe DB; Halliday GM; Dzamko N
Sci Rep; 2016 Aug; 6():31391. PubMed ID: 27503089
[TBL] [Abstract][Full Text] [Related]
6. Selective LRRK2 kinase inhibition reduces phosphorylation of endogenous Rab10 and Rab12 in human peripheral mononuclear blood cells.
Thirstrup K; Dächsel JC; Oppermann FS; Williamson DS; Smith GP; Fog K; Christensen KV
Sci Rep; 2017 Aug; 7(1):10300. PubMed ID: 28860483
[TBL] [Abstract][Full Text] [Related]
7. Centrosomal cohesion deficits as cellular biomarker in lymphoblastoid cell lines from LRRK2 Parkinson's disease patients.
Fernández B; Lara Ordóñez AJ; Fdez E; Mutez E; Comptdaer T; Leghay C; Kreisler A; Simonin C; Vandewynckel L; Defebvre L; Destée A; Bleuse S; Taymans JM; Chartier-Harlin MC; Hilfiker S
Biochem J; 2019 Oct; 476(19):2797-2813. PubMed ID: 31527116
[TBL] [Abstract][Full Text] [Related]
8. Accurate MS-based Rab10 Phosphorylation Stoichiometry Determination as Readout for LRRK2 Activity in Parkinson's Disease.
Karayel Ö; Tonelli F; Virreira Winter S; Geyer PE; Fan Y; Sammler EM; Alessi DR; Steger M; Mann M
Mol Cell Proteomics; 2020 Sep; 19(9):1546-1560. PubMed ID: 32601174
[TBL] [Abstract][Full Text] [Related]
9. Single molecule array measures of LRRK2 kinase activity in serum link Parkinson's disease severity to peripheral inflammation.
Yuan Y; Li H; Sreeram K; Malankhanova T; Boddu R; Strader S; Chang A; Bryant N; Yacoubian TA; Standaert DG; Erb M; Moore DJ; Sanders LH; Lutz MW; Velmeshev D; West AB
Mol Neurodegener; 2024 Jun; 19(1):47. PubMed ID: 38862989
[TBL] [Abstract][Full Text] [Related]
10. Development of phospho-specific Rab protein antibodies to monitor
Lis P; Burel S; Steger M; Mann M; Brown F; Diez F; Tonelli F; Holton JL; Ho PW; Ho SL; Chou MY; Polinski NK; Martinez TN; Davies P; Alessi DR
Biochem J; 2018 Jan; 475(1):1-22. PubMed ID: 29127256
[TBL] [Abstract][Full Text] [Related]
11. A leucine-rich repeat kinase 2 (LRRK2) pathway biomarker characterization study in patients with Parkinson's disease with and without LRRK2 mutations and healthy controls.
Vissers MFJM; Troyer MD; Thijssen E; Pereira DR; Heuberger JAAC; Groeneveld GJ; Huntwork-Rodriguez S
Clin Transl Sci; 2023 Aug; 16(8):1408-1420. PubMed ID: 37177855
[TBL] [Abstract][Full Text] [Related]
12. Phos-tag analysis of Rab10 phosphorylation by LRRK2: a powerful assay for assessing kinase function and inhibitors.
Ito G; Katsemonova K; Tonelli F; Lis P; Baptista MA; Shpiro N; Duddy G; Wilson S; Ho PW; Ho SL; Reith AD; Alessi DR
Biochem J; 2016 Sep; 473(17):2671-85. PubMed ID: 27474410
[TBL] [Abstract][Full Text] [Related]
13. Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation.
Fan Y; Tonelli F; Padmanabhan S; Baptista MAS; Riley L; Smith D; Marras C; Howden A; Alessi DR; Sammler E
J Vis Exp; 2020 Mar; (157):. PubMed ID: 32250352
[TBL] [Abstract][Full Text] [Related]
14. Elevated Urinary Rab10 Phosphorylation in Idiopathic Parkinson Disease.
Wang S; Unnithan S; Bryant N; Chang A; Rosenthal LS; Pantelyat A; Dawson TM; Al-Khalidi HR; West AB
Mov Disord; 2022 Jul; 37(7):1454-1464. PubMed ID: 35521944
[TBL] [Abstract][Full Text] [Related]
15. Development of a multiplexed targeted mass spectrometry assay for LRRK2-phosphorylated Rabs and Ser910/Ser935 biomarker sites.
Nirujogi RS; Tonelli F; Taylor M; Lis P; Zimprich A; Sammler E; Alessi DR
Biochem J; 2021 Jan; 478(2):299-326. PubMed ID: 33367571
[TBL] [Abstract][Full Text] [Related]
16. 'Up with the LRRK': a phosphorylated Rab10 assay for evaluation of LRRK2 activity and inhibitor engagement.
Eyers PA
Biochem J; 2016 Sep; 473(18):2757-62. PubMed ID: 27621483
[TBL] [Abstract][Full Text] [Related]
17. Impact of Type II LRRK2 inhibitors on signaling and mitophagy.
Tasegian A; Singh F; Ganley IG; Reith AD; Alessi DR
Biochem J; 2021 Oct; 478(19):3555-3573. PubMed ID: 34515301
[TBL] [Abstract][Full Text] [Related]
18. Cellular and subcellular localization of Rab10 and phospho-T73 Rab10 in the mouse and human brain.
Singh V; Menard MA; Serrano GE; Beach TG; Zhao HT; Riley-DiPaolo A; Subrahmanian N; LaVoie MJ; Volpicelli-Daley LA
Acta Neuropathol Commun; 2023 Dec; 11(1):201. PubMed ID: 38110990
[TBL] [Abstract][Full Text] [Related]
19. Genetic background influences LRRK2-mediated Rab phosphorylation in the rat brain.
Kelly K; Chang A; Hastings L; Abdelmotilib H; West AB
Brain Res; 2021 May; 1759():147372. PubMed ID: 33600829
[TBL] [Abstract][Full Text] [Related]
20. Roles of lysosomotropic agents on LRRK2 activation and Rab10 phosphorylation.
Kuwahara T; Funakawa K; Komori T; Sakurai M; Yoshii G; Eguchi T; Fukuda M; Iwatsubo T
Neurobiol Dis; 2020 Nov; 145():105081. PubMed ID: 32919031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
